Indoco Remedies informs about board meeting outcome
Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Indoco Remedies has informed that the Board of Directors of the Company at its Meeting held today, 06th November, 2025 has considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2025 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.
The above information is a part of company’s filings submitted to BSE.
